InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,486.61
(
0.16%
)
US TECH 100
19,320.80
(
0.55%
)
Dow Jones
39,188.30
(
0.15%
)
Brent Oil
85.14
(
0.79%
)
Bitcoin
62,186.00
(
2.26%
)
Post# of 27410
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

orangecat

Send PM Follow Ignore
Followers 6
Posts 720
Boards Moderated 0
Alias Born 07/29/2006

orangecat

Re: orangecat post# 8754

Friday, 05/12/2017 10:47:10 AM

Friday, May 12, 2017 10:47:10 AM

Post# of 27410
Hmmm. I didn't pick up on it before, because I was listening to the Q1 call in my car and did not see the slides. The REFRESH 1 study treatment group patients were treated with dual Cytosorb cartridges. So, double any calculations of potential Cytosorb sales for complex cardiac surgery.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CTSO News
More CTSO News
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!